Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.
Metrics to compare | ANUH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANUHPeersSector | |
---|---|---|---|---|
P/E Ratio | 19.8x | 29.8x | −0.5x | |
PEG Ratio | −0.95 | 0.77 | 0.00 | |
Price/Book | 2.8x | 3.3x | 2.6x | |
Price / LTM Sales | 1.3x | 3.9x | 3.3x | |
Upside (Analyst Target) | - | 15.2% | 43.3% | |
Fair Value Upside | Unlock | −2.4% | 6.9% | Unlock |